JP2012107046A5 - - Google Patents

Download PDF

Info

Publication number
JP2012107046A5
JP2012107046A5 JP2012035170A JP2012035170A JP2012107046A5 JP 2012107046 A5 JP2012107046 A5 JP 2012107046A5 JP 2012035170 A JP2012035170 A JP 2012035170A JP 2012035170 A JP2012035170 A JP 2012035170A JP 2012107046 A5 JP2012107046 A5 JP 2012107046A5
Authority
JP
Japan
Prior art keywords
olopatadine
polyvinylpyrrolidone
solution composition
composition
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012035170A
Other languages
English (en)
Japanese (ja)
Other versions
JP5328947B2 (ja
JP2012107046A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012107046A publication Critical patent/JP2012107046A/ja
Publication of JP2012107046A5 publication Critical patent/JP2012107046A5/ja
Application granted granted Critical
Publication of JP5328947B2 publication Critical patent/JP5328947B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2012035170A 2001-06-27 2012-02-21 局所投与のためのオロパタジン処方物 Expired - Lifetime JP5328947B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30131501P 2001-06-27 2001-06-27
US60/301,315 2001-06-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010069010A Division JP2010150292A (ja) 2001-06-27 2010-03-24 局所投与のためのオロパタジン処方物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013061887A Division JP2013127005A (ja) 2001-06-27 2013-03-25 局所投与のためのオロパタジン処方物

Publications (3)

Publication Number Publication Date
JP2012107046A JP2012107046A (ja) 2012-06-07
JP2012107046A5 true JP2012107046A5 (enExample) 2013-05-09
JP5328947B2 JP5328947B2 (ja) 2013-10-30

Family

ID=23162841

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2003508332A Expired - Lifetime JP4827374B2 (ja) 2001-06-27 2002-06-19 局所投与のためのオロパタジン処方物
JP2009048628A Withdrawn JP2009114213A (ja) 2001-06-27 2009-03-02 局所投与のためのオロパタジン処方物
JP2010069010A Withdrawn JP2010150292A (ja) 2001-06-27 2010-03-24 局所投与のためのオロパタジン処方物
JP2012035170A Expired - Lifetime JP5328947B2 (ja) 2001-06-27 2012-02-21 局所投与のためのオロパタジン処方物
JP2013061887A Withdrawn JP2013127005A (ja) 2001-06-27 2013-03-25 局所投与のためのオロパタジン処方物

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2003508332A Expired - Lifetime JP4827374B2 (ja) 2001-06-27 2002-06-19 局所投与のためのオロパタジン処方物
JP2009048628A Withdrawn JP2009114213A (ja) 2001-06-27 2009-03-02 局所投与のためのオロパタジン処方物
JP2010069010A Withdrawn JP2010150292A (ja) 2001-06-27 2010-03-24 局所投与のためのオロパタジン処方物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013061887A Withdrawn JP2013127005A (ja) 2001-06-27 2013-03-25 局所投与のためのオロパタジン処方物

Country Status (20)

Country Link
US (2) US6995186B2 (enExample)
EP (1) EP1399127B1 (enExample)
JP (5) JP4827374B2 (enExample)
KR (1) KR100884711B1 (enExample)
CN (1) CN1211125C (enExample)
AR (1) AR034619A1 (enExample)
AT (1) ATE295149T1 (enExample)
AU (1) AU2002310461B2 (enExample)
BR (1) BRPI0210707B8 (enExample)
CA (1) CA2447924C (enExample)
DE (1) DE60204142T2 (enExample)
DK (1) DK1399127T3 (enExample)
ES (1) ES2238574T3 (enExample)
GC (1) GC0000397A (enExample)
MX (1) MXPA03011947A (enExample)
PL (1) PL205565B1 (enExample)
PT (1) PT1399127E (enExample)
TW (1) TWI231759B (enExample)
WO (1) WO2003002093A1 (enExample)
ZA (1) ZA200308771B (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100055152A1 (en) * 2008-08-26 2010-03-04 Trutek Corporation Antihistamine and antihistamine-like nasal application, products, and method
US7977376B2 (en) * 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US20050209312A1 (en) * 2004-03-19 2005-09-22 Bausch & Lomb Incorporated Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative
KR101252863B1 (ko) * 2004-04-08 2013-04-09 교와 핫꼬 기린 가부시키가이샤 안정성이 향상된 고형 제제 및 그 제조 방법
US20070225356A1 (en) * 2004-04-21 2007-09-27 Kyowa Hakko Kogo Co., Ltd Preventive and/or Therapeutic Agent for Chronic Sinusitis
MXPA06014648A (es) * 2004-06-28 2007-02-12 Alcon Inc Formulaciones topicas para tratar pacedimientos alergicos.
DK1814538T3 (da) * 2004-11-24 2009-11-02 Alcon Inc Fremgangsmåde til administration af næsespray
WO2006097458A1 (en) * 2005-03-15 2006-09-21 Nycomed Gmbh Novel combination
WO2007007863A1 (en) 2005-07-08 2007-01-18 Senju Pharmaceutical Co., Ltd. Percutaneously absorptive ophthalmic preparation comprising olopatadine
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
US20080114076A1 (en) * 2006-11-09 2008-05-15 Alcon Manufacturing Ltd. Punctal plug comprising a water-insoluble polymeric matrix
TWI409081B (zh) 2006-11-09 2013-09-21 Alcon Res Ltd 用於藥物輸送之水不溶性聚合物基質
BRPI0720431A2 (pt) * 2006-12-18 2013-12-31 Alcon Res Ltd Dispositivos e métodos para a distribuição de fármaco oftálmico
WO2008093358A2 (en) * 2007-01-29 2008-08-07 Sun Pharmaceutical Industries Limited Aqueous topical solution containing olopatadine
WO2008097220A1 (en) * 2007-02-07 2008-08-14 Alcon, Inc. Olopatadine formulations for topical nasal administration
WO2008120249A1 (en) * 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
RU2009141592A (ru) * 2007-04-11 2011-05-20 Алькон Рисерч, Лтд. (Us) ПРИМЕНЕНИЕ ИНГИБИТОРА TNFα В СОЧЕТАНИИ С АНТИГИСТАМИННЫМ СРЕДСТВОМ ДЛЯ ЛЕЧЕНИЯ АЛЛЕРГИЧЕСКОГО РИНИТА И АЛЛЕРГИЧЕСКОГО КОНЪЮНКТИВИТА
US20100227917A1 (en) * 2007-09-06 2010-09-09 Masashi Nakakura EYE DROP CONTAINING DIBENZ[b,e]OXEPIN DERIVATIVE
BRPI0912985A2 (pt) * 2008-05-19 2015-10-13 Alcon Res Ltd composições farmacêuticas com polímero de carboxivinila e polímero de povidona
CN102089039B (zh) * 2008-08-26 2013-10-23 博磊科技股份有限公司 带静电荷口罩过滤产品和用于增加过滤效率的方法
KR20110056526A (ko) * 2008-08-28 2011-05-30 트루텍 코프. 항히스타민 및 유사-항히스타민 코 외용약, 생성물 및 방법
US9458198B1 (en) 2009-06-26 2016-10-04 Shire Orphan Therapies Gmbh Cyclic peptide-based NPR-B agonists
AU2010273347B2 (en) * 2009-07-17 2015-04-30 Alcon Research, Ltd. Olopatadine nasal spray regimen for children
WO2011027322A1 (en) * 2009-09-03 2011-03-10 Ranbaxy Laboratories Limited Extended release dosage form containing olopatadine for oral administration
RU2557290C2 (ru) * 2009-09-25 2015-07-20 Шайр Орфан Терапис ГмбХ Новые агонисты npr-b
US8551938B2 (en) * 2009-09-25 2013-10-08 Alcon Research, Ltd. NPR-B agonists
RU2012117141A (ru) * 2009-10-01 2013-11-10 Алькон Рисерч, Лтд. Композиции олопатадина и способы их применения
WO2011075471A2 (en) 2009-12-18 2011-06-23 Alcon Research, Ltd. Novel npr-b agonists and methods of use for the treatment of c-type natriuretic peptide-mediated disorders
TW201121995A (en) 2009-12-18 2011-07-01 Alcon Res Ltd Novel NPR-B agonists
CN103140215A (zh) * 2010-07-21 2013-06-05 爱尔康研究有限公司 具有提高的溶解度特征的药物组合物
US20120264681A1 (en) * 2010-11-08 2012-10-18 Healor Ltd. Buffered ophthalmic compositions and methods of use thereof
TWI544922B (zh) * 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠(olopatadine)眼用組成物
CN102885767A (zh) * 2012-11-02 2013-01-23 江苏吉贝尔药业有限公司 一种新的盐酸奥洛他定滴眼液及其制备方法
MA47418A (fr) 2017-02-01 2021-06-02 Takeda Pharmaceuticals Co Composés et compositions pour le traitement de troubles ophtalmiques
JP7037349B2 (ja) * 2017-06-23 2022-03-16 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
WO2018235935A1 (ja) * 2017-06-23 2018-12-27 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
JPWO2021112240A1 (enExample) * 2019-12-06 2021-06-10
TWI896607B (zh) * 2020-03-31 2025-09-11 日商參天製藥股份有限公司 填充於樹脂製容器之含銀鹽眼科用水性組合物
CN111700860A (zh) * 2020-07-09 2020-09-25 浙江尖峰药业有限公司 盐酸奥洛他定滴眼液及其制备方法
CN119318630B (zh) * 2024-10-16 2025-08-22 苏州欧康维视生物科技有限公司 一种阿托品药物组合物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370324A (en) 1980-09-17 1983-01-25 Bernstein Joel E Method and composition for treating and preventing irritation of the eyes
US4407791A (en) 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4749700A (en) * 1984-10-23 1988-06-07 Nastech Pharmaceutical Co, Inc. Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) * 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
ES2053678T3 (es) * 1987-11-13 1994-08-01 Asta Medica Ag Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular.
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
JP3662944B2 (ja) 1993-08-24 2005-06-22 協和醗酵工業株式会社 点鼻剤
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
US5641805A (en) * 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
WO1998056381A1 (en) * 1997-06-09 1998-12-17 Bridge Pharma, Inc. Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
DK1037627T3 (da) 1998-07-14 2001-10-01 Alcon Lab Inc Anvendelse af 11-(3-dimethylamino-propyliden)-6, 11-dihydrodibenz[b,e]oxepin-2-eddikesyre og af farmaceutisk acceptable salte deraf til fremstillingen af et lægemiddel til behandlingen af non-allergiske...
US6146622A (en) 1998-10-27 2000-11-14 Alcon Laboratories, Inc. Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
AU753462B2 (en) * 1998-10-27 2002-10-17 Alcon Laboratories, Inc. Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
US6274626B1 (en) * 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
US6174914B1 (en) * 1999-06-15 2001-01-16 Alcon Laboratories, Inc. Method of inhibiting cytokine release from human ocular cells
AU7363700A (en) 1999-09-21 2001-04-24 Alcon Laboratories, Inc. Use of fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topical pharmaceutical compositions
US6649602B1 (en) 1999-11-18 2003-11-18 Alcon, Inc. Use of an H1 antagonist and a safe steroid to treat eye conditions
ATE291913T1 (de) 2000-01-25 2005-04-15 Alcon Inc Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen
AR031135A1 (es) 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
BR0316203A (pt) 2002-11-12 2005-10-04 Alcon Inc Uso de um agente antialérgico e um esteróide para tratar rinite alérgica

Similar Documents

Publication Publication Date Title
JP2010150292A5 (enExample)
JP2015500794A5 (enExample)
AR118582A2 (es) Procedimiento para producir sílice precipitada tratada
JP2004536096A5 (enExample)
MX354456B (es) Silicato de zirconio microporoso para el tratamiento de hipercalemia.
JP2012532115A5 (enExample)
RU2013150861A (ru) Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний
WO2011158042A3 (en) Ureido- pyrazole derivatives for use in the treatment of rhinovirus infections
MX360684B (es) Silicato de zirconio microporoso para el tratamiento de la hipercalemia.
JP2012092139A5 (enExample)
GEP201706780B (en) Substituted 2-aza-bicyclo [2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
EA201990616A3 (ru) Дендримероподобные аминоамиды, обладающие активностью блокаторов натриевых каналов, для лечения сухости глаз и других заболеваний слизистых оболочек
NZ607580A (en) N-heteroaryl compounds
JP2009519312A5 (enExample)
JP2014139241A5 (enExample)
EP4249431A3 (en) Compositions and methods for treating diseases or disorders using extended release nitric oxide releasing solutions
RU2012103458A (ru) Композиции, включающие финафлоксации, и способы лечения офтальмологических, ушных или назальных инфекций
EP2328550A4 (en) MUKOADHÄRENTE COMPOSITIONS AND ITS USE
JP2019142974A5 (enExample)
AR082049A1 (es) Formulaciones liquidas de rupatadina fumarato
RU2009122281A (ru) Средство для лечения заболеваний в ветеринарии на основе соли фосфония
EP4591928A3 (en) Composition for the treatment of gastroesophageal reflux comprising hyaluronic acid
HRP20180178T1 (hr) Pripravci ketorolaka, namijenjeni zacjeljivanju rane na rožnici
JP2016534062A5 (enExample)
PH12015502717A1 (en) Anti-fibrogenic compounds, methods and uses thereof